Singapore, July 04, 2012: The growing elderly population and its associated disease burden add to the economic challenge...
Singapore: As a part of Australian Business Week in India (ABWI) 2015, the 19 member Australian Health and Life Sciences...
Singapore: The medical device regulators of Australia, Brazil, Canada and the US have all signed on to a statement of co...
Singapore: Research on treatment of Alzheimer's disease received a fillip with Australian scientists working on it recei...
Singapore: India generated the nearly one-fourth of the global revenue of the lifescience market in APAC. Highlig...
Singapore: Australia was the third largest contributor to the lifescience market in the region Highlights • An ...
Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...
Singapore: AdiStem, a provider of photo activation technology and medical solutions, highlighted that platelet rich pla...
Singapore: AusBiotech, the bioscience industry organization of Australia, has told the government that patent length in ...
Valentine's Day, which is marked as a day to commemorate the death anniversary of Saint Valentine, saw the birth of a ve...
Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...
Singapore: Dr Anna Lavelle, CEO, AusBiotech, has been elected to Fellowship of the Australian Academy of Technological S...
Singapore: Australia's healthcare company focused on investing in and developing next generation technologies, Admedus, ...
With 11 percent share and $11.65 billion is revenue, Australia grew marginally. It has been a bad year or Australia's...
Singapore: Australia-based Mayne Pharma has struck a deal to acquire Doryx acne-treatment brand and assets in the US for...
Singapore: Australia's regenerative medicine company, Orthocell, has recieved Chinese patent for its Collagen Scaffold f...
Singapore: Serum Institute of India (SII) has applied for permits to export flu vaccines produced using Australia's BioD...
Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...
The press release indicated that Immutep is a French company and is a 100 percent subsidiary of Prima BioMed. Immutep de...
Singapore: Melbourne-based Phosphagenics has resolved all crystallisation issues associated with its opioid patch devel...
Singapore: In July 2013, Therapeutics Goods Administration, Australia, had published a guidance on biosimlar naming base...
Singapore: Australia based Novotech has strengthened its Hong Kong operation with expansion of its manpower base. The c...
Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appe...
Singapore: US-based AirStrip recently inked a pact with Life Monitor, a subsidiary of Cardioscan, to sell AirStrip solut...
Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children m...
One of the challenges in the R&D of next generation vaccines is the development of a delivery technology that will b...
When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in rece...
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...
Singapore: Australia's QRxPharma has collaborated with Canadian specialty pharmaceutical company, Paladin Labs on licens...
Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...
Singapore: Gilead Sciences' head of commercial operations for the past decade, Mr Kevin Young, who oversaw tremendous sa...
Singapore: Australian Prime Minister Mr Tony Abbott said that the nation is contracting a private company to staff and o...
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...
Singapore: The next Viralytics clinical study evaluating multi doses of CAVATAK administered by the intravenous route ...
Singapore: Pharmaxis received a complete response letter from the US FDA confirming that Bronchitol cannot yet be appro...
Singapore: Asia-Pacific, including Japan, China, India, New Zealand, South Korea and Australia, is the fastest growing r...
Singapore: CDC predicts that every year, one in every three adults in the age group of 65 or older falls and around 2 mi...
Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...
Singapore: Australia boasts an advanced healthcare system supported by both the public and private sector involvement. T...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...
Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...
Singapore: Australia-based Cynata Therapeutics has made a breakthrough by devising a technique to mass manufacture stem ...
Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...
Singapore: CSL announced that it has clinched a deal with the Victorian government to expand its Melbourne plasma manufa...
Singapore: Telezon's flagship SoloFlow Reconstitution Needle (polymer needle) has been accepted by Therapeutic Goods Aus...
Singapore: Australia based Allied Healthcare has started commercializing CardioCel into Europe after the Company receive...
Singapore: 22nd Century Group, a company that has developed pioneering technology for tobacco harm reduction and smoking...
Singapore: Cancer Council NSW, Australia's non-government cancer research funder, has granted almost $7 million to resea...
Singapore: US-Australian drug discovery company, Novogen, in conjunction with Australian paediatric cancer researchers, ...
Singapore: Australian drug discovery company, Novogen, has developed anti-tropomyosin drug candidate, Anisina, which has...
Singapore: Australia-based Starpharma Holdings has achieved improved tumor-inhibiting efficacy and reduced overall toxic...
Singapore: Biosensis has announced the launch of its new range of Rapid ELISA kits. The company has released fifteen new...
Singapore: Australian drug delivery technology company, Phosphagenics, will be returning to the clinic with its oxycodo...
Singapore: An extensive study commissioned by Polycom, a global service provider, highlighted that lack of funding and g...
Singapore: Australia based pharmacuetical company, Starpharma, has appointed Mr Robert Thomas to the Board as a non-exec...
Singapore: Australia's Balnaves Foundation has donated $450,000 to the University of Sydney's medical school to help pro...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), and Helsinn, a Swiss group fo...
Singapore: A study conducted by Australian researchers from the Western Australian Institute for Medical Research (WAIMR...
Singapore: US based Celgene Corporation, a global biopharmaceutical, has agreed to acquire shares of Australia's regener...
Singapore: Leading nucleic acid-based drug discovery and development firm Marina Biotech has announced a worldwide expan...
Singapore: Australian scientists have confirmed a 'weak link' in the immune system, identifying the exact conditions und...
Singapore: A 12 member Australian Life sciences & Health care delegation is visiting India from 15 to 19 September t...
Singapore: Phase II clinical trials by scientists from the National Institute of Allergy and Infectious Diseases (NIAID)...
Singapore: Australia's National Health and Medical Research Council (NHMRC) has taken up the task of implementing initia...
Singapore: An 82-year-old prostate cancer patient has become the first person in Australia to be treated using the fast ...
Singapore: As per a recent news report, an Australian traveler to Japan has been diagnosed with dengue fever. As per the...
Singapore: New Zealand-based cancer diagnostic specialist Pacific Edge has completed the first commercial sales of Cxbla...
Singapore: Medtronic announced the submission of its first pre-market approval (PMA) module to the US Food and Drug Admi...
Sydney-headquartered Regeneus announced the completion of enrolment of all 20 patients in the STEP trial. Further, a rev...
In 2011, the Bill & Melinda Gates Foundation rolled out a new grant of $31 million to fund innovation in point-of-ca...
Singapore: ResMed has won an import ban in the US against a Taiwanese device manufacturer alleged to be infringing on th...
Singapore: US-based Harlan Laboratories, a leading contract research organization (CRO) and research models and service...
Endoluminal Sciences, an Australia-based company, is developing a breakthrough technology for the treatment of failing h...
Singapore: India's Sun Pharmaceuticals and Australia's CSL are the only two drugmakers that have been featured in the Fo...
Singapore: Australia-based Prana Biotechnology has achieved positive result in its phase II clinical trial investigating...
Singapore: Australia based Avita Medical, a medical device company specializing in the treatment of wounds and skin defe...
Singapore: A US government investigation started at the request of ResMed against Taiwanese manufacturer Apex Medical ha...
Singapore: Australia-based AmpliPhi Biosciences is looking to acquire Brookvale, a Sydney-based Special Phage Services (...
Dr Shinya Yamanaka and Sir John Gurdon's discovery of induced pluripotent stem cells (iPS) has given the world an altern...
Singapore: Researchers at Griffith Health Institute's Genomics Research Center have entered the final phase in an extens...
The Medical Technology Association of Australia (MTAA) is the national association of Australia representing companies i...
Singapore: US-based Ariad Pharmaceuticals has granted Specialised Therapeutics Australia (STA), a specialty pharmaceutic...
Singapore: The federal government in Australia has initiated a review of the patenting of pharmaceuticals in the country...
Singapore: Takeda Development Center Shanghai (TDC Shanghai) and Takeda Development Center Asia has commenced TOURMALINE...
Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...
Singapore: US FDA has accepted the transfer of ownership of 23 generic drug products to Australia based IDT. Formalising...
Singapore: US-based Catalant Pharma Solutions announced the acquisition of Pharmapak Technologies, an Australian pharmac...
Singapore: In a bid to eradicate the menace of TB, The Australian Department of Foreign Affairs and Trade (DFAT) has ann...
Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...
Singapore: Specialty pharmaceutical company Hatchtech has completed a $6 million financing led by OneVentures Innovatio...
Singapore: West Australian sandalwood producer TFS Corporation has announced the acquisition of two US pharma firms in a...
Singapore: NICTA start-up company Saluda Medical has been awarded $5 million by the New South Wales Government to suppor...
Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has detailed a new phase of res...
Singapore: There must have been many Indian prime ministers who have visited Australia before. But this one by the curre...
Singapore: Over six research groups have treated more than 120 patients with many different types of blood and bone-marr...
Singapore: Monash Institute of Pharmaceutical Sciences (MIPS) has been recognised for the Monash-GSK Australian Centre f...
Singapore: Recently GlaxoSmithKline has announced introduction of a new technology to its Boronia manufacturing site in ...
